A retinoid, vitamin A derivative that promotes skin cell turnover to reduce pore size, clear spots, and smooth fine lines.
Adapalene is a third-generation retinoid derivative of vitamin A.
The ingredient was developed in the late 1980’s and first approved by the FDA in 1996 as a skincare treatment for acne. It gained similar approval in the UK in 2003.
Adapalene advanced dermatology by offering a clinically proven and reliable long-term prescription topical treatment for acne, ageing skin, and hyperpigmentation.
Registered Address: International House, 6 South Molton Street, London W1K 5QF, United Kingdom
Trading Address: Unit 2C Gazelle Buildings, Wallingford Road, Uxbridge UB8 2RW, United Kingdom
© Monderma 2024. All Rights Reserved.
Monderma uses cookies to improve your online experience. Please let us know if you agree to this.